# QuVa Pharma, Inc., Bloomsbury, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/quva-pharma-inc/1852735f-efbc-4896-9ba0-465f07d479e6

> Inspection records and compliance data for QuVa Pharma, Inc. in Bloomsbury, New Jersey. 4 FDA inspections on record (3 OAI), 3 Form 483s, 1 warning letter, last inspected April 04, 2025.

---

## Details

- Name: QuVa Pharma, Inc.
- FEI Number: 3013931875
- Facility Type: Outsourcing Facility
- Address Line 1: 519 State Route 173
- City: Bloomsbury
- State: New Jersey
- Zip Code: 08804
- Country Name: United States
- Address: 519 State Route 173, Bloomsbury, New Jersey 08804, United States
- Country: United States

## Related Documents

- [FDA Inspection 1263856 - QuVa Pharma, Inc. - 2025-04-04](https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/259a7990-3b8e-4a0e-a0dc-9e9775b09d44) — classification: Official Action Indicated (OAI), source: FDA, date: April 4, 2025
- [WARNING_LETTER - QuVa Pharma, Inc. - 2022-10-14](https://www.keypedia.com/records/warning_letter/quva-pharma-inc/4dfc2843-4da2-4f5c-a7d2-ac6b7365a71e) — source: FDA, date: October 14, 2022
- [483 - QuVa Pharma, Inc. - 2022-10-14](https://www.keypedia.com/records/483/quva-pharma-inc/6c4d72be-6439-44e2-9ff8-61595de2ce6a) — source: FDA, date: October 14, 2022
- [FDA Inspection 1181531 - QuVa Pharma, Inc. - 2022-10-14](https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/778f28d6-99c1-496e-a459-f584b73a0745) — classification: Official Action Indicated (OAI), source: FDA, date: October 14, 2022
- [483 - QuVa Pharma, Inc. - 2022-08-18](https://www.keypedia.com/records/483/quva-pharma-inc/59535d99-826d-4405-be15-8b10bb5cde4f) — source: FDA, date: August 18, 2022
- [483 - QuVa Pharma, Inc. - 2019-05-31](https://www.keypedia.com/records/483/quva-pharma-inc/8cd7d039-95c1-4202-b52c-748d3117bb36) — source: FDA, date: May 31, 2019
- [FDA Inspection 1094744 - QuVa Pharma, Inc. - 2019-05-31](https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/59bffd82-fe85-49e1-bb9b-c11c65c5849e) — classification: Official Action Indicated (OAI), source: FDA, date: May 31, 2019
- [483 - QuVa Pharma, Inc. - 2019-04-23](https://www.keypedia.com/records/483/quva-pharma-inc/18f5b923-5e6c-4138-ae7b-8b6483eaa65e) — source: FDA, date: April 23, 2019
- [483 - QuVa Pharma, Inc. - 2019-03-14](https://www.keypedia.com/records/483/quva-pharma-inc/ac997419-c9b0-4f1b-9875-97a2b70ddc77) — source: FDA, date: March 14, 2019
- [483 - QuVa Pharma, Inc. - 2017-11-30](https://www.keypedia.com/records/483/quva-pharma-inc/db7a8ffe-e43a-4fef-be20-cac0f6d0f13f) — source: FDA, date: November 30, 2017
- [FDA Inspection 1032363 - QuVa Pharma, Inc. - 2017-11-30](https://www.keypedia.com/records/fda_inspections/quva-pharma-inc/41fbc22e-37e0-4057-b95d-f3701e59c7b6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 30, 2017
- [483 - QuVa Pharma, Inc. - 2017-06-02](https://www.keypedia.com/records/483/quva-pharma-inc/1e39698c-7d20-4ed8-ae3a-29f14b507519) — source: FDA, date: June 2, 2017
- 145 - QuVa Pharma, Inc. - 2017-03-24 — source: FDA, date: March 24, 2017
- [483 - QuVa Pharma, Inc. - 2016-02-08](https://www.keypedia.com/records/483/quva-pharma-inc/f5b994d3-bc39-4f4f-b07c-2aa707677294) — source: FDA, date: February 8, 2016

## Related Companies

- [Stokes Healthcare Inc. dba Epicur Pharma](https://www.keypedia.com/companies/stokes-healthcare-inc-dba-epicur-pharma/5690f008-b17d-45e0-8976-d917b007f02f)
- [ImprimisRx CA, Inc., dba ImprimisRx](https://www.keypedia.com/companies/imprimisrx-ca-inc-dba-imprimisrx/4fe86729-76bc-40f3-ba28-530af52598c6)
- [Medivera Compounding Pharmacy](https://www.keypedia.com/companies/medivera-compounding-pharmacy/85d05a2e-2537-48e6-ae57-70debd2c31ec)
- [Dorneyville Pharmacy](https://www.keypedia.com/companies/dorneyville-pharmacy/5e58dda6-23b6-4ea5-847e-d249563dac0a)
- [Compounding Pharmacy of America](https://www.keypedia.com/companies/compounding-pharmacy-of-america/830c4791-7e4c-4fa8-97d6-52d2578e6eef)
- [Kings Park Slope Inc](https://www.keypedia.com/companies/kings-park-slope-inc/b30e167e-f7b8-45f7-a05b-a3c12ac0693e)
- [JMA Partners](https://www.keypedia.com/companies/jma-partners/412b6773-4c98-4648-81f9-67dcdde0a216)
- [Stonegate Pharmacy LP](https://www.keypedia.com/companies/stonegate-pharmacy-lp/f7c2ae1a-3694-4030-b0f7-b37e0794a48d)
- [CareFirst Specialty Pharmacy LLC](https://www.keypedia.com/companies/carefirst-specialty-pharmacy-llc/e2e28801-ae52-498b-8776-4b35c1ed0247)
- [Sandoz Inc](https://www.keypedia.com/companies/sandoz-inc/754ea1c4-cac0-44a3-a842-fdecd9df9ecd)

## Related Officers

- [Principal Consultant](https://www.keypedia.com/people/stephen-d-brown/01ff1439-f6d7-4501-a104-573dae30d306)
- [Investigator](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)
- [Margaret M. Annes](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)
- [Strategic Accounts Operations Manager / Account Executive](https://www.keypedia.com/people/aqualia-l-nelson/8ceeb15a-29d4-4924-aca0-0a7c86761a82)
- [Investigator](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)
